LDS/Medical Tests/Alveolar Soft Part Sarcoma (ASPS)/Renal Cell Carcinoma (RCC), Xp11.23 (TFE3), FISH, Tissue

Alveolar Soft Part Sarcoma (ASPS)/Renal Cell Carcinoma (RCC), Xp11.23 (TFE3), FISH, Tissue

Alveolar soft part sarcoma (ASPS) is a rare and slow-growing tumor mainly found in children and young adults. On the molecular level it is characterized by a translocation involving the Alveolar Soft Part Sarcoma Chromosomal Region Candidate Gene 1 Protein (ASPSCR1), a gene on chromosome 17 and the Transcription Factor for Immunoglobulin Heavy-Chain Enhancer 3 (TFE3) gene on an X chromosome. The most common translocations are t(X:17)(p11:q25) and t(X;1) (p11.2;q21). The protein product of the ASPSCR1-TFE3 fusion gene is a stronger transcriptional activator than TFE3 alone. The diagnosis of ASPS is important for both treatment and prognostication as the tumor has a high mortality rate due to metastasis occurring years later after the initial diagnosis.

Renal cell carcinoma (RCC) is also associated with TFE3 gene fusion occurring from a balanced reciprocal translocation of Xp11.2 to either ASPSCR1 (17q25), PRCC (1q21), PSF (1q34), NonO (Xq12) and CLTC (17q23. RCC is a very common type of cancer in adults and has a poor prognosis. Although RCC is a serious disease, early diagnosis and proper treatment are associated with lower mortality.

Since translocation involving the TFE3 transcription factor located at Xp11.2 locus is a common characteristic in both ASPS and RCC, the following diagnostic tests are commonly used to identify the presence of such mutations: immunohistochemistry (IHC) to identify TFE3 protein, traditional karyotyping, break-apart or dual fusion probe FISH and detection of chimeric TFE3 mRNA fusion transcripts using reverse transcriptase-polymerase chain reaction (RT-PCR). Of these methods IHC has limited utility due to the background staining problems and FISH appears to be the simplest and most reliable method for identifying TFE3 rearrangements.

  • As an aid in the diagnosis of alveolar soft-part sarcoma or renal cell carcinoma
  • Therapy monitoring, disease management and prognosis
  • As an aid in diagnosis of TFE3 mutations in other tumors

For Break-apart FISH

  • Yellow or green-red signal patterns mean normal cell (with no TFE3 gene rearrangement).
  • Break-apart signals appear as green and red signal that are separated through a distance more than one signal diameter, indicating one reciprocal of Xp11.2 translocation.
  • Females have two fusion signals, but males have 1 fusion signal due to presence of one X chromosome.
  • Results are positive when >10% of cells showing split green-red signals.

For Dual-fusion probe FISH

  • Formation of yellow and abutting green-red signals as fusion signal indicate a TFE3 gene fusion.
  • Appearance of two simultaneous signals is responsible for 2 fusion genes.
  • Females have 2 split green and 2 red signals, but males have 1 green and 2 red signals for every nucleus
  • Results are positive when >2% of cells showing split green-red signals

Negative for ASPL-TFE3 fusion genes (No rearrangement of the TFE3 gene region was identified)

Fluorescent in situ Hybridization (FISH) using break-apart or/and dual-fusion probe.

A formalin-fixed, paraffin-embedded (FFPE) tumor tissue.

Stability

FFPEs are stable at room temperature for long time.

Kidney biopsy, Synovial Sarcoma (SS), 18q11.2 (SS18 or SYT) Rearrangement, FISH, Ewing Sarcoma (EWS) 22q12 Rearrangement, FISH, Angiosarcoma, MYC (8q24) Amplification, FISH.
5-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login